Difference between revisions of "Sponsors/GenScript"

m
m (Protected "Sponsors/GenScript" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(10 intermediate revisions by 3 users not shown)
Line 7: Line 7:
 
<div class="oneColumn">
 
<div class="oneColumn">
  
−
<h1>GenScript Call for Proposals </h1>  
+
<h1>Special promotion for 2016 iGEM teams: receive 20% off Gene Synthesis and Cloning services!</h1>
  
−
<h2>Proposals due May 1, 2016</h2>
 
−
</div>
 
  
−
<div class="twoColumns" background_gray>
+
<img src="https://static.igem.org/mediawiki/2016/4/49/GenScript_2.png" width="950px">
−
<p>
+
 
−
Is your iGEM team looking to use the hottest gene editing technology to advance important research and clinical problems?  The CRISPR/Cas9 technology has quickly revolutionized gene editing, with significant implications on the advancement of synthetic biology.  In 2016, GenScript is calling for iGEM team proposals that enable CRISPR/Cas9 in the development of biologically useful model systems and tools.
+
<h2>$5,000 grant to accelerate synthetic biology through CRISPR/Cas9 gene editing</h2>
−
</p>
+
−
</div>
+
  
−
<div class="twoColumns">
 
−
<a href="http://www.genscript.com/igem.html"> <img src="https://static.igem.org/mediawiki/igem.org/a/a6/HQ_sponsor_genscript.jpg" width="400px"></a>
 
 
<p>
 
<p>
−
<a href="http://www.genscript.com/igem.html">Learn more about how to apply for GenScript’s CRISPR/Cas9 iGEM team funding opportunity!</a>
+
Is your iGEM team looking to use the hottest gene editing technology to advance important research and clinical problems?  The <strong>CRISPR/Cas9 technology</strong> has quickly revolutionized gene editing, with significant implications on the advancement of synthetic biology.  In 2016, GenScript is calling for iGEM team proposals <a hreg="http://www.genscript.com/igem.html">that advance the application of CRISPR/Cas9 in synthetic biology</a>.  In addition, GenScript is also offering <a href="http://www.genscript.com/igem.html">20% off gene synthesis and cloning services</a> to help them with their projects!
 
</p>
 
</p>
 
</div>
 
</div>
  
−
<!--
 
−
<a href="https://2016.igem.org/Sponsors/IDT"><img class="imageHover" src="https://static.igem.org/mediawiki/2016/6/6c/Idt_banner_image.png" WIDTH="920PX"></A>
 
−
-->
 
  
−
<div class="oneColumn">
+
<div class="twoColumns background_gray">
 +
 
 +
<h3>Call for Proposals – CRISPR/Cas9</h3>
 +
<h4>Proposals due June 30, 2016
 +
</h4>
  
 
<p>
 
<p>
−
Since its establishment in 2002, GenScript has been a leading provider of gene synthesis services to support life science research, translational biomedical research, and early stage pharmaceutical development. GenScript’s custom gene synthesis has accelerated synthetic biology research in many facets, from protein engineering to metabolic engineering, and more recently CRISPR genome editing.  As one of the first companies to license CRISPR/Cas9 products from the Broad Institute, GenScript strives to support high quality CRISPR/Cas9 services and materials to support scientists harness the power of CRISPR genome editing in their research.
+
This year, GenScript is requesting project proposals from iGEM teams that focus on the CRISPR technology.   
 
</p>
 
</p>
  
−
<h2>Call for Proposal Details</h2>
+
<p>
 +
<u>Potential projects include:</u>
 +
<ul>
 +
<li>Developing new gRNA design tools</li>
 +
<li>Engineering CRISPR to power therapeutics development</li>
 +
<li>Harnessing CRISPR for more accurate genome editing in organisms other than mammalian, such as plant, yeast, bacteria, etc.</li>
 +
</ul>
  
 
<p>
 
<p>
−
In 2016, GenScript seeks to support iGEM teams to <a href="http://www.genscript.com/igem.html">advance the application of CRISPR/Cas9 in synthetic biology</a>.  Examples of projects GenScript is seeking to fund include:
+
<u>Reward Details:</u>
 
</p>
 
</p>
 
<ul>
 
<ul>
−
<li>Developing new CRISPR gRNA design tools;</li>
+
<li>Up to 10 teams will be awarded a $5,000 grant</li>
−
<li>Engineering CRISPR to power therapeutics development;</li>
+
<li>Funds will be available by June 30, 2016</li>
−
<li>Harnessing CRISPR for more accurate genome editing in organisms other than mammalian, such as yeast, bacteria, plants, etc.</li>
+
 
</ul>
 
</ul>
  
−
<h2>Reward Details</h2>
 
−
<p>
 
−
Awarded teams will receive a grant of up to $5,000 USD. Up to 10 teams will be awarded.
 
 
<p>
 
<p>
 +
<u>Proposal and application</u>
 +
<ul>
 +
<li><a href="https://static.igem.org/mediawiki/2016/f/f8/GenScript_Corporate_Innovation_Proposals_03222016.pdf">Download proposal details</a></li>
 +
<li>Proposal must be emailed to <strong>igem (at) genscript (dot) com by May 1, 2016</strong>.  Teams will be notified of their award by May 30, 2016.</li>
 +
</ul>
 +
 +
</div>
 +
 +
<div class="twoColumns">
 +
 +
<h3>Special promotion: receive 20% off Gene Synthesis and Cloning Services</h3>
  
−
<h2>Proposal and application</h2>
 
 
<p>
 
<p>
−
Interested iGEM teams may submit a proposal with the following:
+
GenScript is also providing a special discount for all iGEM teams!  Each team can receive <a href="http://www.genscript.com/igem.html">20% off gene synthesis and cloning services</a>.
 +
</p>
 +
 
 
<p>
 
<p>
 +
To receive the discount, use the promo code iGEM2016MB20%OFF and include your team name when you place the quote.  The discount is available until October 31, 2016.
 +
</p>
 +
 +
 +
<br>
 +
<a href="http://www.genscript.com/igem.html">
 +
    <div class="button">
 +
        LEARN MORE!
 +
    </div>
 +
</a>
 +
<br>
 +
 +
 +
</div>
 +
<div class="clear"> </div>
 +
 +
<div class="oneColumn">
 +
 +
<h2>Synthetic Biology and GenScript</h2>
 +
  
−
<ol>
 
−
<li>A description of the intended project: maximum of 2 pages with a 100 word executive summary</li>
 
−
<li>The potential applications and implications of the project</li>
 
−
</ol>
 
  
 
<p>
 
<p>
−
Please email the proposal to <strong>igem (at) genscript (dot) com</strong> by May 1, 2016 for consideration.  
+
The rapidly expanding science of synthetic biology is a field that GenScript, the leading synthetic biology company in the world and the No. 1 gene synthesis supplier in North America, has helped pioneer since 2002. Since de novo gene synthesis is not dependent on naturally occurring DNA templates, sequences can be generated that encode for novel proteins, metabolic circuits or whole genomes.  With the advent of novel DNA parts, there are few limitation towards advancing synthetic biology.
−
</p>
+
−
 
+
−
<p> Teams will be notified of their award by May 30, 2016. Teams will be notified of their award by May 30, 2016, and funds will be available to the teams by June 30, 2016.
+
 
</p>
 
</p>
  
 
<p>
 
<p>
−
For more information, please send your questions to <strong>igem (at) genscript (dot) com</strong>.
+
The discovery of the CRISPR/Cas9 gene editing technology has vastly accelerated the field of synthetic biology, enabling the development of novel cell lines and synthesis of important metabolites and proteins. With a license from the only CRISPR patent holder, GenScript strives to facilitate CRISPR research by offering a variety of gRNA constructs, genome-wide libraries, as well as CRISPR-edited mammalian cell lines and microbes. In 2016, GenScript is offering sponsorship opportunities for iGEM teams striving to advance the potential of CRISPR gene editing.
 
</p>
 
</p>
 +
</div>
 +
<div class="clear"> </div>
 +
 +
<div class="twoColumns background_gray">
 +
<h3>Want to learn more about Gene Synthesis & Molecular Cloning?</h3>
 +
 +
<br>
 +
<a href="http://www.genscript.com/gsh.html"> Download our free Gene Synthesis Handbook!</a>
 +
<br>
 +
</div>
 +
 +
<div class="twoColumns background_gray">
 +
 +
<h3>Curious about CRISPR?  Want to know more?</h3>
 +
 +
<br>
 +
<a href="http://www.genscript.com/crispr-handbook.html"> Download our free CRISPR Handbook!</a>
 +
<br>
  
 
</div>
 
</div>
  
 +
<br><br><br>
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 18:02, 10 June 2016

Special promotion for 2016 iGEM teams: receive 20% off Gene Synthesis and Cloning services!

$5,000 grant to accelerate synthetic biology through CRISPR/Cas9 gene editing

Is your iGEM team looking to use the hottest gene editing technology to advance important research and clinical problems? The CRISPR/Cas9 technology has quickly revolutionized gene editing, with significant implications on the advancement of synthetic biology. In 2016, GenScript is calling for iGEM team proposals that advance the application of CRISPR/Cas9 in synthetic biology. In addition, GenScript is also offering 20% off gene synthesis and cloning services to help them with their projects!

Call for Proposals – CRISPR/Cas9

Proposals due June 30, 2016

This year, GenScript is requesting project proposals from iGEM teams that focus on the CRISPR technology.

Potential projects include:

  • Developing new gRNA design tools
  • Engineering CRISPR to power therapeutics development
  • Harnessing CRISPR for more accurate genome editing in organisms other than mammalian, such as plant, yeast, bacteria, etc.

Reward Details:

  • Up to 10 teams will be awarded a $5,000 grant
  • Funds will be available by June 30, 2016

Proposal and application

  • Download proposal details
  • Proposal must be emailed to igem (at) genscript (dot) com by May 1, 2016. Teams will be notified of their award by May 30, 2016.

Special promotion: receive 20% off Gene Synthesis and Cloning Services

GenScript is also providing a special discount for all iGEM teams! Each team can receive 20% off gene synthesis and cloning services.

To receive the discount, use the promo code iGEM2016MB20%OFF and include your team name when you place the quote. The discount is available until October 31, 2016.


LEARN MORE!

Synthetic Biology and GenScript

The rapidly expanding science of synthetic biology is a field that GenScript, the leading synthetic biology company in the world and the No. 1 gene synthesis supplier in North America, has helped pioneer since 2002. Since de novo gene synthesis is not dependent on naturally occurring DNA templates, sequences can be generated that encode for novel proteins, metabolic circuits or whole genomes. With the advent of novel DNA parts, there are few limitation towards advancing synthetic biology.

The discovery of the CRISPR/Cas9 gene editing technology has vastly accelerated the field of synthetic biology, enabling the development of novel cell lines and synthesis of important metabolites and proteins. With a license from the only CRISPR patent holder, GenScript strives to facilitate CRISPR research by offering a variety of gRNA constructs, genome-wide libraries, as well as CRISPR-edited mammalian cell lines and microbes. In 2016, GenScript is offering sponsorship opportunities for iGEM teams striving to advance the potential of CRISPR gene editing.

Want to learn more about Gene Synthesis & Molecular Cloning?


Download our free Gene Synthesis Handbook!

Curious about CRISPR? Want to know more?


Download our free CRISPR Handbook!